Filter
796
Text search:
stigmatization
Featured
Recommendations
68
New Publications
166
Language
Document type
No document type
480
Studies & Reports
116
Guidelines
76
Strategic & Response Plan
39
Manuals
37
Training Material
17
Fact sheets
16
Situation Updates
11
Infographics
3
Resource Platforms
1
Countries / Regions
Liberia
36
Sierra Leone
33
Global
25
India
23
Nigeria
22
Western and Central Europe
21
Latin America and the Carribbean
19
Guinea
15
Ghana
15
Africa
13
Congo, Democratic Republic of
11
Tanzania
11
Zambia
10
Kenya
10
Ethiopia
9
Uganda
9
Rwanda
9
West and Central Africa
9
Nepal
8
Bangladesh
8
Eastern Europe
8
Malawi
7
Ukraine
7
Haiti
6
Syria
6
Cambodia
6
Indonesia
6
South Africa
6
Lesotho
6
Yemen
6
South–East Asia Region
6
Asia
6
South Sudan
5
Myanmar / Burma
5
Venezuela
5
Vietnam
5
Iraq
4
Colombia
4
East and Southern Africa
4
Albania
4
Russia
4
Zimbabwe
3
Philippines
3
Germany
3
Thailand
3
Mozambique
3
Namibia
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Laos
3
Moldova
3
Georgia
3
Burkina Faso
2
Senegal
2
Cameroon
2
Pakistan
2
China
2
Madagascar
2
Palestine
2
Tajikistan
2
USA
1
Somalia
1
Jordan
1
Afghanistan
1
Lebanon
1
Malaysia
1
Papua New Guinea
1
Sudan
1
Benin
1
Central African Republic
1
Argentina
1
Peru
1
Brazil
1
North Macedonia
1
Hungary
1
Botswana
1
Greece
1
Angola
1
Mexico
1
Sri Lanka
1
Poland
1
Italy
1
Southern Africa
1
Canada
1
Bulgaria
1
Estonia
1
Romania
1
Lithuania
1
Slovakia
1
Japan
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
238
Clinical Guidelines
37
Public Health
31
Women & Child Health
31
Key Resources
14
Capacity Building
5
Pharmacy & Technologies
3
Annual Report MEDBOX
2
Toolboxes
HIV
119
Mental Health
118
COVID-19
115
Disability
61
TB
54
Ebola
51
NTDs
32
Refugee
24
Conflict
18
Rapid Response
17
Caregiver
8
Planetary Health
8
Global Health Education
7
Zika
5
Cholera
3
Natural Hazards
2
Polio
1
Specific Hazards
1
AMR
1
NCDs
1
An estimated 1.3 billion people – or 16% of global population worldwide – experience a significant disability today. Persons with disabilities have the right to the highest attainable standard of health as those without disabilities. However, the WHO Global report on health equity for persons w
...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri
...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat
...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da
...
The COVID-19 pandemic has raised profound ethical challenges on an unprecedented global scale. These challenges include how to allocate scarce resources (especially vaccines and therapeutics), both within and between countries, whether and when to mandate vaccines and/or masks, whether and how to co
...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres
...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci
...
The MHPSS MSP is an easy-to-follow intersectoral package, which spells out the activities and actions that all humanitarian actors should put in place in all emergencies for an effective MHPSS response. It speaks to different actors at the global, regional, national, and local levels to plan, coordi
...
A qualitative assessment of knowledge gaps about female genital schistosomiasis among communities living in Schistosoma haematobium endemic districts of Zanzibar and Northwestern Tanzania.
PloS Neglected Tropical Diseases September 30, 2021 https://doi.org/10.1371/journal.pntd.0009789
Schistosoma
...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi
...
Trachoma is an eye infection that for thousands of years caused many people to go blind across all continents. As the result of development and targeted interventions, trachoma is now limited to an estimated 57 countries, often affecting the poorest
populations of the world. Today, more than 2 mill
...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022
Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense challenge, but the payoff is more effective and sustainable experiences, with higher social awareness
...
Lymphatic filariasis (LF) infection if untreated results in fluid accumulation in the limbs or breasts (lymphedema) or genitalia (hydrocele) that is painful and causes great discomfort. Morbidity management and disability prevention (MMDP) strategies such as surgery for hydrocele, treatment of acute
...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re
...
Conflicts and disasters, including pandemics, affect women and men in all their diversity differently, and women and girls often suffer the most. Crisis-related hardships combine and compound pre-existing disadvantages, for example, they often cause women’s working conditions to worsen while incre
...
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt
...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po
...
Despite the existence of criminal law, which is an important aspect of anti-FGM policies and programmes, there is not much research on the effects of cross-border practices that invalidate the law as a deterrent. Much remains unknown about the practice of cross-border FGM, specifically about gaps in
...
Promoting health and preventing disease is a critical component of the effort required to achieve Universal Health Coverage (UHC). to date, efforts to achieve UHC have focused mostly on strengthening health systems and their capacities to provide curative care. However, experience from the COVID-19
...
Since the beginning of the Ukraine crisis on 24 February 2022, WHO has supported Government-led efforts and initiatives alongside key partners on the ground. Building on efforts to date, and working alongside Bulgaria’s health authorities to bring added value to existing mechanisms, the WHO Countr
...
